Ypsomed Aktie
337,50CHF | 7,50CHF | 2,27% |
WKN: A0B8VP / ISIN: CH0019396990
Aktionärsstruktur
Inhaber | in % |
---|---|
Wilhelm Michel, PhD | 71,84 |
Freefloat | 26,62 |
American Funds Small Cap World Fund | 1,79 |
Simon Michel | 1,30 |
Michel Family | 1,00 |
Premier Miton Investment Fds. 3 - European Opportunities Fund | 0,86 |
SaraSelect | 0,66 |
Government Pension Fund - Global (The) | 0,66 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Personal am Ende des Jahres | 1 714 | 1 824 | 1 831 | 1 978 | 2 296 |
Umsatz pro Mitarbeiter in Mio. EUR | 0,23 | 0,22 | 0,25 | 0,25 | 0,24 |
Bilanz (in Mio. CHF) - Aktiva
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Summe Umlaufvermögen | 186 | 185 | 194 | 208 | 338 |
Summe Anlagevermögen | 488 | 533 | 563 | 654 | 763 |
Summe Aktiva | 675 | 718 | 757 | 862 | 1 101 |
Bilanz (in Mio. CHF) - Passiva
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Summe Fremdkapital | 300 | 322 | 364 | 300 | 484 |
Summe Eigenkapital | 375 | 395 | 393 | 562 | 618 |
Summe Passiva | 675 | 718 | 757 | 862 | 1 101 |
Adresse
Brunnmattstrasse 6, 3401 Burgdorf | |
Telefon | +41 (34) 424-41-11 |
Internet | http://www.ypsomed.com |
Management
Betül Susamis Unaran
Non-Executive Director |
Frank Mengis
Chief Operating Officer |
Gilbert Achermann
Chairman |
Martin C. Münchbach
Independent Non-Executive Director |
Michael Zaugg
Chief Corporate Officer |
Nicolas Meyer
Chief Legal Officer |
Paul R. Fonteyne
Independent Non-Executive Director |
Samuel Künzli
Chief Financial Officer & Member-Executive Board |
Sebastien Delarive
Co-Chief Business Officer |
Simon Michel
Chief Executive Officer & Director |
Thomas Kutt
Head-Investor Relations |
Ulrike Bauer
Co-Chief Business Officer |